I agree with what you are saying. If we don't have at least 5 patients by now then I'm not expecting results next year. We have a high burn rate of cash and this will only grow with more sites opening up. You only have to look at the only customer we had Newphase , they now develop their own Nanoparticles and are about to start phase 1 trials and being in Israel looks like they will complete trials before IBX. Time to move to another country now if there has been no substantial uptake in patients.
IBX Price at posting:
7.2¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)